Was The Smart Money Right About CRISPR Therapeutics AG (CRSP)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Crispr Therapeutics Ag (CRSP)
Market is closed
News
- First
- << Previous
- 51 - 60
- Next >>
5 Best Genomics Stocks to Buy Now
CRISPR Therapeutics AG (NASDAQ:CRSP) is a Swiss-American biotech company that is home to the CRISPR/Cas9 gene-editing technology that is working on treating cancer, diabetes, hemoglobinopathies, and other...
Cathie Wood’s ARK Portfolio: Top 15 Losers
In this article, we discuss the 15 biggest losers in the portfolio of Cathie Wood's ARK.
Hedge Funds Piled Into CRISPR Therapeutics AG (CRSP) At The Wrong Time
We at Insider Monkey have gone over 867 13F filings that hedge funds and prominent investors are required to file by the SEC.
10 Growth Stocks to Buy According to Jay Chen’s Himension Capital
In this article article, we reviewed Jay Chen’s investment philosophy and portfolio management strategies. We also examined 10 growth stocks to buy according to Jay Chen’s Himension Capital.
11 Best Genomic Stocks to Buy Now
Genomics is a branch of biology that studies the structure, function, evolution, mapping, and editing of genomes, which refer to the complete set of DNA of an organism, as opposed to genetics, which is...
Hedge Funds Are Piling Into CRISPR Therapeutics AG (CRSP)
A whopping number of 13F filings filed with U.S.
12 Best ARK Stocks To Invest In
As technology and growth stocks surged during the pandemic, ARK Investment Management and Cathie Wood became two of retail investors' favorites over the previous year.
Hedge Funds Aren't Crazy About CRISPR Therapeutics AG (CRSP) Anymore
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Fund and Insider Trading News: Brevan Howard Asset Management, Elliott Management, Canyon Capital Partners, Vizsla Resources (VIZSF), and More
Brevan Howard Asset Management has stopped accepting new cash into its two biggest multi-manager funds after the firm’s record year of performance swelled the money pools.
- First
- << Previous
- 51 - 60
- Next >>
Billionaire Hedge Funds
